BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

373 related articles for article (PubMed ID: 11733272)

  • 21. Pattern of presentation and outcome of ophthalmic rhabdomyosarcoma in Ibadan.
    Fasina O
    Afr J Med Med Sci; 2013 Jun; 42(2):165-9. PubMed ID: 24377202
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Ocular and Periocular Tumors in Xeroderma Pigmentosum: A Study of 120 Asian Indian Patients.
    Kaliki S; Jajapuram SD; Maniar A; Mishra DK
    Am J Ophthalmol; 2019 Feb; 198():146-153. PubMed ID: 30336128
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [Rhabdomyosarcoma of the orbits in childhood].
    Humpl T; Brühl K; Pitz S; de Mooy P; Bartels U; Gutjahr P
    Ophthalmologe; 1997 Dec; 94(12):914-9. PubMed ID: 9487763
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Metastatic melanoma in the eye and orbit.
    Zografos L; Ducrey N; Beati D; Schalenbourg A; Spahn B; Balmer A; Othenin-Girard CB; Chamot L; Egger E
    Ophthalmology; 2003 Nov; 110(11):2245-56. PubMed ID: 14597536
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Pediatric tumors of the eye and orbit.
    Castillo BV; Kaufman L
    Pediatr Clin North Am; 2003 Feb; 50(1):149-72. PubMed ID: 12713110
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Clinical features associated with survival of patients with lymphoma of the ocular adnexa.
    Jenkins C; Rose GE; Bunce C; Cree I; Norton A; Plowman PN; Moseley I; Wright JE
    Eye (Lond); 2003 Oct; 17(7):809-20. PubMed ID: 14528242
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [Neoplastic space-occupying lesions of the orbit. I. Review; hemangioma, lymphangioma and embryonal rhabdomyosarcoma].
    Gloor B; Kalman A
    Klin Monbl Augenheilkd; 1992 Nov; 201(5):291-301. PubMed ID: 1479785
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [Evaluation of the results of treatment orbital rhabdomyosarcoma in children].
    Chipczyńska B; Grałek M; Hautz W; Kanigowska K; Kocyła-Karczmarewicz B; Trzebicka A; Kepa B
    Klin Oczna; 2007; 109(1-3):18-21. PubMed ID: 17687906
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Prognostic factors for relapse and survival among patients with ocular adnexal lymphoma: validation of the eighth edition of the American Joint Committee on Cancer (AJCC) TNM classification.
    Kwon M; Lee JS; Lee C; Yoon DH; Sa HS
    Br J Ophthalmol; 2021 Feb; 105(2):279-284. PubMed ID: 32327417
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Multidisciplinary treatment of primary orbital rhabdomyosarcoma. A single-institution experience.
    Fiorillo A; Migliorati R; Grimaldi M; Vassallo P; Canale G; Tranfa F; Uccello G; Fiore M; Muto P; Menna G
    Cancer; 1991 Feb; 67(3):560-3. PubMed ID: 1985749
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Embryonal sarcoma of the orbit. A clinical review of 19 Danish cases.
    Fledelius H
    Acta Ophthalmol (Copenh); 1976 Dec; 54(6):693-703. PubMed ID: 990019
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Implant brachytherapy: a novel treatment for recurrent orbital rhabdomyosarcoma.
    Abramson DH; Fass D; McCormick B; Servodidio CA; Piro JD; Anderson LL
    J AAPOS; 1997 Sep; 1(3):154-7. PubMed ID: 10532778
    [TBL] [Abstract][Full Text] [Related]  

  • 33. The cytological, immunocytochemical and molecular genetic analysis in diagnosis of the neoplasms of the eye, eye adnexa and orbit.
    Krzystolik Z; Rosławska A; Bedner E
    Doc Ophthalmol; 1994; 88(2):155-63. PubMed ID: 7781483
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Uveal metastasis from lung cancer: clinical features, treatment, and outcome in 194 patients.
    Shah SU; Mashayekhi A; Shields CL; Walia HS; Hubbard GB; Zhang J; Shields JA
    Ophthalmology; 2014 Jan; 121(1):352-357. PubMed ID: 23988200
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Correlation of surgical outcome with neuroimaging findings in periocular lymphangiomas.
    Gündüz K; Demirel S; Yagmurlu B; Erden E
    Ophthalmology; 2006 Jul; 113(7):1231.e1-8. PubMed ID: 16730067
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Second-line therapy in young patients with relapsed or refractory orbital rhabdomyosarcoma.
    Zloto O; Minard-Colin V; Boutroux H; Brisse HJ; Levy C; Kolb F; Bolle S; Carton M; Helfre S; Orbach D
    Acta Ophthalmol; 2021 May; 99(3):334-341. PubMed ID: 32833335
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Lymphoproliferative diseases of the ocular adnexa in Korea.
    Oh DE; Kim YD
    Arch Ophthalmol; 2007 Dec; 125(12):1668-73. PubMed ID: 18071120
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Multidisciplinary management of refractory orbital rhabdomyosarcoma.
    Mannor GE; Rose GE; Plowman PN; Kingston J; Wright JE; Vardy SJ
    Ophthalmology; 1997 Jul; 104(7):1198-201. PubMed ID: 9224476
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Outcome of patients with localized orbital sarcoma who relapsed following treatment on Intergroup Rhabdomyosarcoma Study Group (IRSG) Protocols-III and -IV, 1984-1997: a report from the Children's Oncology Group.
    Raney B; Huh W; Hawkins D; Hayes-Jordan A; Million L; Rodeberg D; Teot L; Anderson J;
    Pediatr Blood Cancer; 2013 Mar; 60(3):371-6. PubMed ID: 22961750
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Orbital invasion by periocular basal cell carcinoma.
    Leibovitch I; McNab A; Sullivan T; Davis G; Selva D
    Ophthalmology; 2005 Apr; 112(4):717-23. PubMed ID: 15808267
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 19.